股票代码：002772 股票简称：众兴菌业 债券代码：128026 债券简称：众兴转债 公告编号：2021-108 天水众兴菌业科技股份有限公司 2021 年第三季度报告 天水众兴菌业科技股份有限公司 2021 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 重要内容提示: 1、董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整，不存在虚假记载、 误导性陈述或重大遗漏，并承担个别和连带的法律责任。 2、公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）声明：保证季度报告中财务信 息的真实、准确、完整。 3、第三季度报告是否经过审计 □ 是 √ 否 一、主要财务数据 （一）主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □ 是 √ 否 | | 本报告期 | 本报告期比上年 | 年初至报告期末 | 年初至报告期末 | | --- | --- | --- | --- | --- | | | | 同期增减 | | 比上年同期增减 | | 营业收入（元） | 354,740,225.91 | -11.43 ...

Financial Performance - The company's operating revenue for the first half of 2021 was CNY 704,358,946.32, representing an increase of 11.22% compared to CNY 633,323,421.04 in the same period last year[21]. - The net profit attributable to shareholders decreased by 77.69% to CNY 12,531,495.37 from CNY 56,172,012.02 in the previous year[21]. - The net profit after deducting non-recurring gains and losses was CNY -15,224,715.34, a decline of 141.73% compared to CNY 36,487,398.51 in the same period last year[21]. - The net cash flow from operating activities was CNY 108,645,002.15, down 38.93% from CNY 177,907,967.99 in the previous year[21]. - Basic earnings per share fell by 78.45% to CNY 0.0354 from CNY 0.1643 in the same period last year[21]. - The operating cost increased by 25.50% to CNY 607,818,676.06, primarily due to increased production volume and rising raw material prices[59]. - The gross profit margin for the agricultural planting industry was 13.71%, down by 9.82% year-on-year[63]. Assets and Liabilities - Total assets increased by 9.15% to CNY 6,092,929,786.33 from CNY 5,581,944,186.22 at the end of the previous year[21]. - The net assets attributable to shareholders rose by 14.01% to CNY 3,111,507,572.32 from CNY 2,729,105,527.77 at the end of the previous year[21]. - The company's inventory stood at ¥278,655,082, which is 4.57% of total assets, showing a slight decrease of 0.10% compared to the previous year[68]. - Long-term borrowings rose to ¥1,750,765,650, accounting for 28.73% of total assets, an increase of 10.32% from 18.41% last year, driven by additional loans for daily operations and project construction[68]. Operational Developments - The company expanded its sales channels, with increased sales through fresh e-commerce, chain restaurants, and supermarkets[30]. - The company is advancing several projects, including the expansion of its mushroom cultivation facilities and the construction of a circular economy industrial park[30]. - The company is actively seeking new profit growth points, including a cash acquisition of 100% equity in Guizhou Maotai Town Shengjiao Liquor Co., Ltd.[31]. - The company has established production bases in multiple provinces, including Gansu, Shaanxi, Shandong, and others, ensuring coverage of major national markets[52]. Governance and Management - The company is committed to improving its governance structure and has completed the election of the fourth board of directors and supervisory board[32]. - The company has implemented a stable profit distribution policy to return value to shareholders, in accordance with the regulations set forth by the China Securities Regulatory Commission[110]. - The company has implemented an employee stock ownership plan with a scale of up to 9 million shares, with a purchase price of 1 RMB per share, to align employee interests with long-term company development[100]. Market and Competition - The company faces risks from increased competition in the edible mushroom industry, leading to potential price declines due to rapid capacity expansion[85]. - Seasonal fluctuations in sales prices and profits are a concern, with the second quarter typically being a low-demand period for mushrooms[86]. - The company is exploring opportunities for international expansion, particularly in Southeast Asian markets[144]. Environmental and Social Responsibility - The company has established a wastewater treatment facility with a capacity of 600 m³/d, utilizing A/O biological contact oxidation technology, ensuring that treated wastewater meets the Class I discharge standards of GB8978-1996[105]. - The company emphasizes social responsibility, aiming for sustainable development and actively contributing to local economic growth through its operations[109]. - The company practices sustainable development by recycling agricultural by-products and converting waste into organic fertilizers, thus promoting environmental protection[114]. Future Outlook - The company plans to leverage its circular economy advantages by utilizing waste materials for organic fertilizer production, contributing to sustainable practices[55]. - The company plans to expand its market presence by launching new products in the second half of 2021, targeting a 10% increase in market share[145]. - The company has set a performance guidance of 600 million yuan in revenue for the second half of 2021, indicating a positive outlook[144].

天水众兴菌业科技股份有限公司 2021 年第一季度报告全文 2021 年 04 月 1 天水众兴菌业科技股份有限公司 2021 年第一季度报告全文 第一节 重要提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真 实、准确、完整，不存在虚假记载、误导性陈述或者重大遗漏，并承担个别和 连带的法律责任。 所有董事均已出席了审议本次季报的董事会会议。 公司负责人陶军、主管会计工作负责人李敏及会计机构负责人（会计主管 人员）何文科声明：保证季度报告中财务报表的真实、准确、完整。 2 天水众兴菌业科技股份有限公司 2021 年第一季度报告 天水众兴菌业科技股份有限公司 2021 年第一季度报告全文 第二节 公司基本情况 一、主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □ 是 √ 否 | | 本报告期 | 上年同期 | 本报告期比上年同期增减 | | --- | --- | --- | --- | | 营业收入（元） | 395,772,820.20 | 366,584,750.64 | 7.96% | | 归属于上市公司股东的净利润（元） | 43,424,962.07 | 74 ...

Financial Performance - Operating revenue for the reporting period was ¥400,518,483.46, representing a year-on-year growth of 54.84%[9] - Net profit attributable to shareholders was ¥64,494,424.51, a significant increase of 735.94% compared to the same period last year[9] - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥48,735,690.89, up 344.46% year-on-year[9] - Basic earnings per share for the reporting period was ¥0.1897, reflecting a growth of 765.61% compared to the same period last year[9] - The company's net profit for Q3 2020 reached CNY 121,080,149.93, a significant increase from CNY 39,857,373.16 in the same period last year, representing a growth of approximately 203%[67] - Operating profit for the third quarter was CNY 120,589,532.27, compared to CNY 39,262,088.17 in Q3 2019, indicating a year-over-year increase of about 207%[67] - The total comprehensive income for the third quarter was CNY 64,099,984.91, compared to a loss of CNY 10,248,452.42 in the previous year[60] Assets and Liabilities - Total assets at the end of the reporting period reached ¥5,458,307,058.50, an increase of 8.88% compared to the end of the previous year[9] - The company's cash and cash equivalents at the end of the reporting period amounted to ¥1,295,672,063.69, an increase of 32.77% compared to the beginning of the year, primarily due to new bank borrowings[17] - The company’s total liabilities due within one year increased by 152.23% to ¥376,137,285.19, attributed to an increase in borrowings due within one year according to the repayment plan[17] - The company's total liabilities increased to CNY 2,803,590,262.28 from CNY 2,410,791,004.22 year-over-year, indicating a rise in financial obligations[52] - Total liabilities reached CNY 2,410,791,004.22, with current liabilities at CNY 404,231,897.58 and non-current liabilities at CNY 2,006,559,106.64[82] Cash Flow - The net cash flow from operating activities was ¥25,075,542.56, down 46.19% year-on-year[9] - The cash inflow from operating activities was CNY 1,091,254,256.00, an increase from CNY 847,785,980.63 in the previous period, representing a growth of approximately 29.5%[74] - The net cash flow from financing activities was CNY 276,749,194.02, a significant drop from CNY 703,286,653.44, representing a decline of approximately 60.7%[75] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 36,812[13] - The largest shareholder, Tao Jun, holds 29.95% of the shares, with 110,136,094 shares pledged[13] - The company repurchased a total of 14,536,516 shares in the second phase of the buyback program, with a total transaction amount of approximately ¥101 million, at a maximum price of ¥8.66 per share and a minimum price of ¥6.13 per share[29] Research and Development - Research and development expenses for the first nine months of 2020 totaled ¥5,119,701.83, a significant increase of 96.07% year-on-year, reflecting higher R&D investments[19] - Research and development expenses for Q3 2020 were CNY 1,753,984.18, up from CNY 1,039,642.72 in the previous year, highlighting a focus on innovation[58] Investment Activities - The company’s investment income for the first nine months of 2020 was ¥2,076,181.65, a decrease of 85.56% year-on-year, primarily due to recognized investment losses from joint ventures and associates[19] - The net cash flow from investing activities for the first nine months of 2020 was -¥143,722,560.37, an improvement from -¥294,335,146.35 in the same period last year, primarily due to reduced investment expenditures on ongoing projects[20] Corporate Governance - The company has implemented its first employee stock ownership plan to align employee interests with long-term corporate development, enhancing overall competitiveness[23] - There are no overdue commitments from actual controllers, shareholders, or related parties during the reporting period[29] Future Outlook - The company is exploring new strategies for market expansion and product development in the upcoming quarters[39] - The company has indicated plans for potential mergers and acquisitions to enhance its market position[39] - The company is committed to ongoing research and development of new technologies to improve operational efficiency[39]

Financial Performance - The company's operating revenue for the first half of 2020 was ¥633,323,421.04, representing a 24.41% increase compared to ¥509,043,588.29 in the same period last year[18]. - The net profit attributable to shareholders of the listed company was ¥56,172,012.02, up 13.28% from ¥49,585,805.88 in the previous year[18]. - The net profit after deducting non-recurring gains and losses was ¥36,487,398.51, an increase of 11.63% compared to ¥32,686,406.68 in the same period last year[18]. - The basic earnings per share increased by 17.61% to ¥0.1643 from ¥0.1397 in the previous year[18]. - The total assets at the end of the reporting period were ¥5,366,196,338.44, a 7.05% increase from ¥5,012,915,611.36 at the end of the previous year[18]. - The net assets attributable to shareholders of the listed company decreased by 0.57% to ¥2,584,723,600.99 from ¥2,599,482,132.26 at the end of the previous year[18]. - The net cash flow from operating activities was ¥177,907,967.99, showing a slight increase of 0.53% compared to ¥176,970,763.60 in the same period last year[18]. - The weighted average return on net assets was 2.16%, up from 1.87% in the previous year, indicating improved profitability[18]. Production and Sales - The company has established production bases for edible fungi in multiple provinces, including Gansu, Shaanxi, Shandong, Jiangsu, Henan, Jilin, Sichuan, Anhui, and Hubei[26]. - The main products are enoki mushrooms and button mushrooms, with enoki mushrooms accounting for over 80% of production and sales[27]. - The company increased edible mushroom production due to the commissioning of new bases in Xinxiang and Anhui, leading to higher output compared to the previous year[28]. - The company has a daily production capacity of 965 tons of edible mushrooms, with enoki mushrooms at 745 tons and button mushrooms at 220 tons, ranking among the industry leaders[42]. - The company’s market share further consolidated and increased, with sales volume growing approximately 20% compared to the same period last year[53]. - The sales revenue from the double mushroom segment surged by 93.03%, amounting to ¥178,630,293.59, compared to ¥92,539,437.79 in the previous year[58]. - The production of edible mushrooms increased by 24.51%, primarily due to the commencement of operations at the Xinxiang Xinghe Phase II and Anhui Zhongxing projects[56]. Investment and Financing - The company has completed the non-public offering of funds, raising a total of RMB 1,176.45 million, with RMB 992.76 million utilized by the reporting period[79]. - The company reported a total of CNY 201.04 million raised from public offerings, with CNY 151.99 million already utilized[77]. - The company has invested CNY 2.67 million from the raised funds during the reporting period[77]. - The company has a total of CNY 663 million in financial assets, with a fair value change of CNY 5.07 million[73]. - The company has a total of 10 subsidiaries, with varying levels of profitability and contributions to the overall financial performance[96]. Risk Management - The company does not foresee any significant adverse risks affecting its production, operation, financial status, or sustainable profitability[5]. - The company faces risks related to product quality instability due to new strains and changes in cultivation media, which may affect profitability[98]. - The company anticipates increased competition in the edible mushroom industry, leading to potential price declines due to rising supply without corresponding demand growth[100]. - The company has established a comprehensive quality control system to mitigate food safety risks, but potential contamination during various stages of production remains a concern[102]. - Fluctuations in raw material prices, particularly for corn cobs and rice bran, have affected production costs, with ongoing volatility expected due to increased downstream demand and extreme weather[104]. Corporate Governance and Compliance - The company has not experienced any significant litigation or arbitration matters during the reporting period[114]. - There were no media inquiries or widespread doubts regarding the company during the reporting period[115]. - The company did not face any penalties or rectification issues during the reporting period[116]. - The company and its controlling shareholders have no records of dishonesty or unfulfilled court judgments[117]. - The company has not made any acquisitions or significant investments in new subsidiaries during the reporting period[97]. Social Responsibility and Community Engagement - The company issued a living subsidy of CNY 10,000 per quarter to ten households in difficulty, totaling CNY 20,000 during the reporting period[153]. - The company invested CNY 83,000 to build a pavilion for villagers in the targeted poverty alleviation area, enhancing both material and cultural support[154]. - The company plans to continue increasing investments in impoverished areas to drive poverty alleviation through industry, prioritizing employment for impoverished households[155]. - The company has actively fulfilled its social responsibility by creating job opportunities for local farmers and promoting the development of related industries[152]. Environmental Compliance - The wastewater treatment facility has a processing capacity of 600 m³/d, utilizing the A/O biological contact oxidation process, and currently operates normally[146]. - The company achieved compliance with the GB8978-1996 Class I standard for wastewater discharge, ensuring that all wastewater is treated before release[146]. - The company is committed to adhering to environmental protection laws and regulations[147]. - The concentration of COD in the treated wastewater was recorded at 76 mg/L, with an annual discharge of 5.99 tons, which is below the permitted limit[145]. Shareholder and Capital Management - The company completed a share repurchase plan, acquiring a total of 14,536,516 shares, approximately 3.95% of the total share capital, for a total amount of CNY 101,002,394.57[157]. - The company plans to distribute a cash dividend of 1.00 yuan per 10 shares to all shareholders, with the remaining undistributed profits carried forward to the next year[163]. - The total number of ordinary shareholders at the end of the reporting period was 34,358[177]. - Major shareholder Tao Jun holds 29.95% of the shares, totaling 110,136,094 shares, with 27,534,024 shares pledged[177]. Future Outlook - Future guidance indicates a continued emphasis on increasing production capacity and improving operational efficiency to meet growing demand[141]. - The company plans to launch new products in the upcoming quarters, aimed at capturing a larger market share[141]. - The management remains optimistic about achieving its financial targets for the year, despite market challenges[141].

Financial Performance - The company's operating revenue for 2019 was ¥1,155,832,460.49, representing a 24.76% increase compared to ¥926,432,056.86 in 2018[18]. - The net profit attributable to shareholders for 2019 was ¥68,403,837.18, a decrease of 38.89% from ¥111,939,025.00 in 2018[18]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥37,975,887.67, down 43.77% from ¥67,539,158.17 in 2018[18]. - The net cash flow from operating activities increased by 54.94% to ¥359,149,932.19 from ¥231,792,554.80 in 2018[18]. - The total assets at the end of 2019 were ¥5,012,915,611.36, a 21.99% increase from ¥4,109,398,363.54 at the end of 2018[18]. - The company reported a basic earnings per share of ¥0.19, down 38.71% from ¥0.31 in 2018[18]. - The company reported a significant increase in cash funds, with a year-end balance of 501.34 million yuan, reflecting a 105.64% increase due to increased long-term borrowings[57]. - The company’s fixed assets increased by 262.51 million yuan, a 14.61% rise, primarily due to the completion of several construction projects[57]. - The company reported a decrease in inventory by 44.81%, indicating improved sales efficiency[74]. - The company reported a total investment of 50,000,000 CNY in a new wholly-owned subsidiary established in Jiangsu[100]. Market and Industry Insights - The edible mushroom industry is experiencing rapid growth, supported by rising food consumption expenditure among urban and rural residents, with GDP increasing from CNY 10,028 billion in 2000 to CNY 99,087 billion in 2019, a growth of approximately 9.88 times[45]. - Urban residents' disposable income rose from CNY 6,256 in 2000 to CNY 42,359 in 2019, while rural residents' disposable income increased from CNY 2,282 to CNY 16,021, representing growth rates of 577% and 602% respectively[45]. - The poultry industry has also seen growth, with the number of poultry increasing from 9.305 billion in 2006 to 14.641 billion in 2019, a rise of 57.36%, providing ample chicken manure for mushroom production[51]. - The restaurant industry in China generated 4.6721 trillion yuan in revenue in 2019, driving demand for processed edible mushrooms[54]. - The edible mushroom industry in China saw a total production of 38.42 million tons in 2018, a 3.5% increase from 2017[126]. - The market value of edible mushrooms reached CNY 293.74 billion in 2018, growing by 7.92% compared to 2017[126]. Production and Operations - The company has established production bases for edible fungi in multiple provinces including Gansu, Shaanxi, and Shandong[28]. - The company has a daily production capacity of 905 tons for edible mushrooms, with 745 tons for enoki mushrooms and 160 tons for button mushrooms, placing it at the forefront of the industry[56]. - The company has completed major projects including a 32,400-ton annual production facility for enoki mushrooms and a 20,000-ton facility for button mushrooms, contributing to a significant increase in production capacity[132]. - The company launched several major projects, including a 32,400-ton gold needle mushroom production project and a 20,000-ton button mushroom production project, which have been completed and put into operation[66]. - The company has established production bases in multiple provinces, including Gansu, Shaanxi, Shandong, Jiangsu, Henan, Jilin, Sichuan, Anhui, and Hubei, ensuring broad market coverage[60]. Research and Development - The company’s research and development capabilities are enhanced by its independent R&D center, which is recognized as a provincial-level technology center and has advanced equipment for mushroom cultivation[42]. - The total R&D investment for 2019 was CNY 13,144,589.85, representing a 7.43% increase from 2018, while the R&D investment as a percentage of operating income decreased to 1.14%[85]. - The company plans to enhance its edible mushroom strain research system and establish an independent strain library to provide high-quality strains to domestic and international markets[130]. - The company aims to improve the quality and yield of edible mushroom products by increasing R&D investment and adopting advanced technologies[133]. Financial Management and Investments - The company has a long-term investment strategy, focusing on sustainable growth and profitability in the agricultural sector[100]. - The company has utilized both self-owned funds and raised capital for its investment projects, ensuring diversified funding sources[105]. - The company has committed to projects totaling RMB 201,035.6 million, with RMB 164,523.6 million already invested[114]. - The company has a remaining balance of RMB 60,078.94 million in unutilized raised funds[108]. - The company raised RMB 90,290 million through the public issuance of convertible bonds, with RMB 51,874.27 million utilized by the end of 2019, leaving RMB 40,262.54 million in the special account[110]. Risk Management - The company emphasizes the importance of risk awareness for investors regarding forward-looking statements and performance forecasts[6]. - The company faces risks related to product quality instability due to new strains and changes in cultivation methods, which could impact profitability[137]. - The company is exposed to price decline risks in the industry due to increased competition and supply exceeding demand[138]. - Seasonal fluctuations in revenue and profit are a concern, with potential impacts from varying consumer demand throughout the year[139]. - The company acknowledges the risk of food safety issues that could arise from production processes, potentially affecting product quality and brand reputation[142]. Corporate Governance and Compliance - The company emphasizes compliance with laws and regulations, ensuring that all related transactions are conducted at fair pricing to protect its interests[163]. - The company has established measures to ensure that any violations of commitments will result in economic liability for the responsible party[163]. - The company has committed to fulfilling its obligations to minority shareholders and has reported compliance with these commitments[171]. - The company is focused on maintaining transparency and accountability in its financial reporting and commitments to investors[167]. - The company has a structured approach to managing potential conflicts of interest and ensuring transparency in its operations[163]. Shareholder Returns - The company reported a cash dividend of 1.00 RMB per 10 shares (including tax) for the 2019 profit distribution plan[6]. - In 2019, the company plans to distribute cash dividends of 1.00 RMB per 10 shares, with a total cash dividend amounting to 36,769,840.90 RMB, maintaining a payout ratio of 53.75% of the net profit attributable to ordinary shareholders[157]. - The total cash dividend for 2019, including other methods, is projected to be 100,771,002.67 RMB, representing 147.32% of the net profit attributable to ordinary shareholders[157]. - The company has not proposed any stock dividends or capital reserve transfers for the reporting period, focusing solely on cash dividends[158].

Financial Performance - Revenue for Q1 2020 was CNY 366,584,750.64, representing a 19.20% increase compared to CNY 307,543,510.25 in the same period last year[9] - Net profit attributable to shareholders was CNY 74,652,655.18, up 10.89% from CNY 67,323,222.85 year-on-year[9] - Net profit excluding non-recurring items reached CNY 69,248,684.55, an 18.24% increase from CNY 58,567,759.87 in the previous year[9] - Basic earnings per share increased by 20.25% to CNY 0.2179 from CNY 0.1812 in the previous year[9] - Operating profit for the quarter was ¥77,863,041.53, compared to ¥67,779,398.38 in the same period last year, reflecting a growth of approximately 14.8%[52] - Net profit attributable to the parent company was ¥74,652,655.18, an increase from ¥67,323,222.85, which is a rise of about 10.5%[52] - The company recorded a total comprehensive income of CNY 13,679,886.77 for the quarter, compared to CNY 10,264,879.84 in the same period last year, representing an increase of about 33.5%[57] Cash Flow - Operating cash flow for the period was CNY 140,871,191.94, reflecting a 7.10% increase from CNY 131,530,749.45 in the same quarter last year[9] - Cash received from other operating activities in Q1 2020 was 11.94 million CNY, a decrease of 52.91% year-over-year, due to fewer government subsidies received[19] - Cash paid for other operating activities in Q1 2020 was 9.35 million CNY, an increase of 74.95% year-over-year, primarily due to unexpected compensation payments[19] - The net cash flow from investing activities was negative at CNY -172,556,845.52, compared to a positive CNY 10,415,063.36 in the previous year, indicating a significant decline[60] - Cash flow from financing activities generated a net inflow of CNY 293,669,013.40, down from CNY 592,499,436.46 in the previous year, reflecting a decrease of approximately 50.4%[61] Assets and Liabilities - Total assets at the end of the reporting period were CNY 5,366,483,508.50, a 7.05% increase from CNY 5,012,915,611.36 at the end of the previous year[9] - The total liabilities of the company were CNY 2,716,380,944.14, compared to CNY 2,410,791,004.22, marking an increase of around 12.66%[44] - The company's equity attributable to shareholders rose to CNY 2,647,116,980.02 from CNY 2,599,482,132.26, which is an increase of about 1.83%[45] - The total current assets reached CNY 2,120,628,195.49, up from CNY 1,820,155,000.10, indicating an increase of about 16.52%[42] - The total cash and cash equivalents increased to CNY 1,226,498,982.47 from CNY 975,903,148.67, reflecting a growth of approximately 25.67%[42] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 35,420[13] - The company repurchased a total of 13,291,116 shares, accounting for 3.61% of the total share capital, with a total transaction amount of approximately 91.08 million CNY[22] - The company plans to repurchase shares with a budget of 100 million to 200 million CNY, with a repurchase price range of 1.00 to 9.00 CNY per share[21] Research and Development - R&D expenses for Q1 2020 amounted to 1.93 million CNY, a significant increase of 321.61% year-over-year, attributed to higher technical service fees[18] - Research and development expenses increased to ¥1,925,272.67 from ¥456,646.44, showing a significant rise of approximately 321.5%[51] Financial Management - The company has entrusted financial management with a total amount of 73,400,000 yuan, with an unexpired balance of 72,700,000 yuan[31] - The entrusted financial management includes 38,000,000 yuan from self-owned funds and 35,400,000 yuan from raised funds[31] - The company has no overdue commitments from actual controllers, shareholders, or related parties during the reporting period[28] - The company has not reported any overdue or unrecoverable amounts in entrusted financial management[34] Compliance and Audit - The company did not conduct an audit for the Q1 2020 report, indicating it was unaudited[72] - The company has no violations regarding external guarantees during the reporting period[35] - The company has not engaged in derivative investments during the reporting period[34]

天水众兴菌业科技股份有限公司 2019 年第三季度报告全文 天水众兴菌业科技股份有限公司 2019 年第三季度报告 2019 年 10 月 1 天水众兴菌业科技股份有限公司 2019 年第三季度报告全文 第一节 重要提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真 实、准确、完整，不存在虚假记载、误导性陈述或者重大遗漏，并承担个别和 连带的法律责任。 所有董事均已出席了审议本次季报的董事会会议。 公司负责人陶军、主管会计工作负责人李敏及会计机构负责人（会计主管 人员）董建军声明：保证季度报告中财务报表的真实、准确、完整。 2 天水众兴菌业科技股份有限公司 2019 年第三季度报告全文 第二节 公司基本情况 一、主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □ 是 √ 否 | | 本报告期末 | 上年度末 | | 本报告期末比上年度末增减 | | --- | --- | --- | --- | --- | | 总资产（元） | 4,945,038,164.50 | | 4,109,398,363.54 | 20.33% | | 归属于上市公司股东的净资产 | 2,614 ...

Financial Performance - The company's operating revenue for the first half of 2019 was CNY 509,043,588.29, representing a 22.76% increase compared to CNY 414,653,870.65 in the same period last year[19]. - The net profit attributable to shareholders of the listed company reached CNY 49,585,805.88, up 33.73% from CNY 37,078,885.89 year-on-year[19]. - The net profit after deducting non-recurring gains and losses was CNY 32,686,406.68, a significant increase of 113.05% compared to CNY 15,342,188.50 in the previous year[19]. - The net cash flow from operating activities was CNY 176,970,763.60, showing a remarkable growth of 179.90% from CNY 63,225,565.31 in the same period last year[19]. - Basic earnings per share increased to CNY 0.1397, reflecting a 37.77% rise from CNY 0.1014 in the previous year[19]. - Total assets at the end of the reporting period were CNY 4,667,268,665.15, which is a 13.58% increase from CNY 4,109,398,363.54 at the end of the previous year[19]. - The net assets attributable to shareholders of the listed company were CNY 2,634,055,209.04, a slight increase of 0.13% from CNY 2,630,515,320.21 at the end of the previous year[19]. - The weighted average return on net assets was 1.87%, an increase of 0.45% compared to 1.42% in the previous year[19]. Production and Capacity - The company has established production bases for edible fungi in multiple provinces, including Gansu, Shaanxi, and Shandong, enhancing its production capacity[27]. - The first phase of the Wuwei Zhongxing base, with an annual production capacity of 32,400 tons of enoki mushrooms, is nearing full production[29]. - The company has a daily production capacity of 775 tons for edible mushrooms, with 655 tons for enoki mushrooms and 120 tons for button mushrooms, placing it at the forefront of the industry[44][48]. - The company continues to implement a strategy focused on "rooted in the Northwest, facing the nation, and moving towards the world" for its production base layout[54]. - The company is expanding its market presence through the establishment of new production lines and projects aimed at increasing production capacity[94]. Research and Development - The company has a dedicated research and development center with advanced facilities, focusing on the innovation of edible fungi production technology[41]. - The company has obtained 111 patents, with several innovations in mushroom cultivation and production processes reaching industry-leading levels[49]. - The company’s R&D investment surged by 1,890.83% to ¥1,571,561.30, reflecting increased activities in research and technical services[61]. - The company aims to improve technical stability and reduce pollution rates while increasing biological conversion rates through enhanced R&D and talent acquisition[119]. Market Strategy - The company is focusing on cost control, technological innovation, and quality improvement to enhance market competitiveness[29]. - The company plans to optimize its product structure and enhance market share by implementing a production base layout strategy and a multi-variety cultivation strategy focused on enoki mushrooms[118]. - The company will leverage its "famous trademark" status in the edible mushroom market to enhance brand awareness and premium capabilities, emphasizing green and safe consumption concepts[119]. Financial Management - The company plans not to distribute cash dividends or issue bonus shares[7]. - The company has made significant investments in construction projects, with ongoing projects increasing by CNY 249,832.1 million, a rise of 48.73%[45]. - The company’s cash and cash equivalents increased by CNY 46,483.26 million, a growth of 97.95%, primarily due to increased project loans[45]. - The company’s financial expenses increased to ¥18,967,582.03 due to interest expenses from convertible bonds and long-term borrowings related to completed projects[61]. Risks and Challenges - The company faces risks from industry competition, which may lead to price declines due to increased supply from new entrants in the edible mushroom market[110]. - There is a risk of contamination from miscellaneous fungi and pests, which can significantly impact production efficiency and product quality[111]. - Seasonal fluctuations in revenue and profit are anticipated, with the second quarter typically being a low season for mushroom consumption[112]. - Food safety risks remain a concern, as contamination during production and distribution could adversely affect product quality and company reputation[114]. - The company is exposed to raw material price volatility, particularly for key inputs like corn husks and rice bran, which could impact profit margins[115]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 37,727[185]. - The largest shareholder, Tao Jun, holds 29.95% of the shares, totaling 110,136,094 shares, with a decrease of 820,521 shares during the reporting period[185]. - The company has a diverse shareholder base, including both natural persons and institutional investors[186]. - The report highlights the absence of any related party transactions among the top shareholders[187]. Corporate Governance - The company has not engaged in any related party transactions during the reporting period[134]. - The company has not sold any significant assets during the reporting period[104]. - The company has not reported any bond payment defaults or issues during the reporting period[199]. - The company’s board of directors and senior management did not experience any changes during the reporting period[194].

天水众兴菌业科技股份有限公司 2019 年第一季度报告全文 第一节 重要提示 天水众兴菌业科技股份有限公司 2019 年第一季度报告全文 天水众兴菌业科技股份有限公司 2019 年第一季度报告 2019 年 04 月 1 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真 实、准确、完整，不存在虚假记载、误导性陈述或者重大遗漏，并承担个别和 连带的法律责任。 所有董事均已出席了审议本次季报的董事会会议。 公司负责人陶军、主管会计工作负责人李敏及会计机构负责人（会计主管 人员）董建军声明：保证季度报告中财务报表的真实、准确、完整。 2 天水众兴菌业科技股份有限公司 2019 年第一季度报告全文 第二节 公司基本情况 一、主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □ 是 √ 否 | | 本报告期 | 上年同期 | 本报告期比上年同期增减 | | --- | --- | --- | --- | | 营业收入（元） | 307,543,510.25 | 267,161,661.05 | 15.12% | | 归属于上市公司股东的净利润（元） | 67,323,222.85 | 8 ...